Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
BTK inhibition enhances immunovirotherapy in glioblastoma via tertiary lymphoid structure modulation.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2026
Blocking Feedback Immunosuppression of Antigen Presentation in Brain Tumor During Oncolytic Virotherapy with oHSV-mshPKR.
Journal: Molecular cancer therapeutics
Published: October 03, 2024
Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial.
Journal: Neuro-oncology
Published: September 16, 2023
Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Journal: Immunity
Published: September 08, 2020
Treg Destabilization and Reprogramming: Implications for Cancer Immunotherapy.
Journal: Cancer research
Published: May 02, 2018
Chemo-Immunotherapy: Role of Indoleamine 2,3-Dioxygenase in Defining Immunogenic Versus Tolerogenic Cell Death in the Tumor Microenvironment.
Journal: Advances in experimental medicine and biology
Published: December 25, 2017
Access to hematopoietic stem cell transplant for patients with sickle cell anemia.
Journal: Pediatric blood & cancer
Published: November 27, 2017
TFE3-positive renal cell carcinoma occurring in three children with dysfunctional kidneys on immunosuppression.
Journal: Pediatric transplantation
Published: February 06, 2017
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.
IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment.
Journal: Cancer immunology, immunotherapy : CII
Published: January 09, 2017
Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors.
Journal: Immunity
Published: December 20, 2016
Early career mentoring through the American Society of Pediatric Hematology/Oncology: Lessons learned from a pilot program.
Journal: Pediatric blood & cancer
Published: June 28, 2016
The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma.
Journal: Journal for immunotherapy of cancer
Published: April 18, 2014
Last Updated: 09/26/2026